Literature DB >> 12523922

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

Barbara Thorand1, Hannelore Löwel, Andrea Schneider, Hubert Kolb, Christa Meisinger, Margit Fröhlich, Wolfgang Koenig.   

Abstract

BACKGROUND: Previous studies have suggested that low-grade systemic inflammation is involved in the pathogenesis of type 2 diabetes mellitus.
OBJECTIVE: To investigate the association between C-reactive protein (CRP), the classic acute-phase protein, and incident type 2 diabetes mellitus among middle-aged men.
METHODS: A total of 2052 initially nondiabetic men aged 45 to 74 years who participated in 1 of the 3 MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) Augsburg surveys between 1984 and 1995 were followed up for an average of 7.2 years. Incidence of diabetes was assessed by questionnaire mailed to participants in 1998. High-sensitive CRP was measured by an immunoradiometric assay.
RESULTS: A total of 101 cases of incident diabetes occurred during the follow-up period. The age-standardized incidence rate was 6.9 per 1000 person-years. Men with CRP levels in the highest quartile (CRP > or = 2.91 mg/L) had a 2.7 times higher risk of developing diabetes (95% confidence interval, 1.4-5.2) compared with men in the lowest quartile (CRP < or = 0.67 mg/L) in a Cox proportional hazards model adjusted for age and survey. After further adjustment for body mass index, smoking, and systolic blood pressure, the observed association was significantly reduced and became nonsignificant.
CONCLUSIONS: Low-grade systemic inflammation is associated with an increased risk of type 2 diabetes mellitus in middle-aged men. Inflammation could be one mechanism by which known risk factors for diabetes mellitus, such as obesity, smoking, and hypertension, promote the development of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12523922     DOI: 10.1001/archinte.163.1.93

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  101 in total

Review 1.  C-reactive protein and risk of cardiovascular disease: evidence and clinical application.

Authors:  Paul M Ridker; Shari S Bassuk; Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 2.  Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?

Authors:  Stephan J L Bakker; Ron T Gansevoort; Erik M Stuveling; Rijk O B Gans; Dick de Zeeuw
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 3.  Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins.

Authors:  David T Nash
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

Review 4.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

5.  Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes.

Authors:  Atif N Qasim; Venkata Budharaju; Nehal N Mehta; Caitlin St Clair; Samira Farouk; Seth Braunstein; Mark Schutta; Nayyar Iqbal; Daniel J Rader; Muredach P Reilly
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

6.  Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial.

Authors:  Paulette D Chandler; Jamil B Scott; Bettina F Drake; Kimmie Ng; Joann E Manson; Nader Rifai; Andrew T Chan; Gary G Bennett; Bruce W Hollis; Edward L Giovannucci; Karen M Emmons; Charles S Fuchs
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-10

7.  Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis.

Authors:  P L Lutsey; J S Pankow; A G Bertoni; M Szklo; A R Folsom
Journal:  Diabet Med       Date:  2009-02       Impact factor: 4.359

8.  Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.

Authors:  C Herder; N Klopp; J Baumert; M Müller; N Khuseyinova; C Meisinger; S Martin; T Illig; W Koenig; B Thorand
Journal:  Diabetologia       Date:  2007-08-22       Impact factor: 10.122

Review 9.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

10.  Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets.

Authors:  G Silbernagel; J Machann; H-U Häring; A Fritsche; A Peter
Journal:  Eur J Clin Nutr       Date:  2013-11-13       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.